Clinical Trial Update: Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating pharmacokinetics, efficacy, safety, and immunogenicity of Wilate in previously treated paediatric patients with severe Hemophili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Wilate (von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Severe Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2019-12-24